Home Regulations & Standards COVID-19: Information for Pharmacy Professionals

COVID-19: Information for Pharmacy Professionals

Page Updated November 3, 2023

Latest updates:

- Updated links in COVID-19 Vaccines Information – Helpful Resources section

Important Reminders:

- As the pandemic continues to evolve, registrants are reminded to review and keep up-to-date on guidance from the Ministry of Health, including monitoring their Microsoft Office 365 email account for updates.

This page provides the latest updates on COVID-19 for pharmacy professionals and is updated frequently. The College continues to collaborate with the Ministry of Health, public health officials and other health system partners and professional associations to inform and support pharmacy professionals.

For the College’s latest email updates, please visit the e-Connect page of our website.

If you are a patient, please visit the COVID-19 Information for Patients webpage.

On January 13, 2021, the provincial government amended Ontario Regulation 107/96 under the Regulated Health Professions Act (RHPA), exempting a part A pharmacist, intern, registered pharmacy student or pharmacy technician from subsection 27 (1) of the Act for the purpose of administering a coronavirus (COVID-19) vaccine by injection.

Community pharmacies offering this service must follow expectations outlined in the Guidance for Providing COVID-19 Services in Community Pharmacies.

The exemption permitting pharmacy professionals to administer the COVID-19 vaccines applies to all age groups, including infants and children six months to five years of age. Authority for pharmacy professionals to administer the COVID-19 vaccine has been extended through to March 31, 2024.

The College has developed a guidance document titled Administration of COVID-19 Vaccine by Pharmacy Professionals which outlines expectations and resources for pharmacy professionals administering COVID-19 vaccines and serves as a supplement to the Executive Officer Notices and other COVID-19 vaccine-relevant guidance from the Ministry of Health, below:

Ministry of Health COVID-19 Vaccine-Relevant Information and Planning Resources
Ministry of Health COVID-19 Vaccine Guidance
Ministry of Health Executive Officer Notices Regarding Vaccine Administration in Pharmacies (updated regularly):
- Administration of Publicly Funded COVID-19 Vaccine in Ontario Pharmacies – Eligibility
- Administration of Publicly Funded COVID-19 Vaccine in Ontario Pharmacies – Billing
- Questions and Answers for Administration of Publicly Funded COVID-19 Vaccine in Ontario Pharmacies

Helpful Resources

Resources for Healthcare Professionals

Canadian Pharmacists Association
Canadian Vaccination Evidence Resource and Exchange Centre (Canadian Public Health Association)
Centre for Effective Practice – COVID-19: Vaccines
Government of Canada
Immunize Canada
- CARD system
- COVID-19 Resources
ISMP Canada Safety Bulletins
National Advisory Committee on Immunization (NACI)
University of Waterloo School of Pharmacy

GUIDANCE AND REPORTING

Guidance on Pharmacy Professionals Wearing Masks

The College expects pharmacy professionals to follow current public health recommendations.

The following is a list of selected resources:

Universal Mask Use in Health Care (Public Health Ontario)
Focus on Universal Mask Use in Healthcare Settings and Retirement Homes (Public Health Ontario)
COVID-19 medical masks and respirators: Information for health professionals (Public Health Agency of Canada)

The College strongly encourages the continued use of masks in all pharmacies to further protect patients and staff, particularly when interacting with patients and providing professional services.

Provincial Guidance for Pharmacies

The Ministry of Health webpage for healthcare providers provides important updates and resources.
COVID-19 Health Care Resources from Public Health Ontario, including infection prevention and control guidance.
Management of Cases and Contacts of COVID-19 in Ontario

Patients and members of the public should be directed to the Ministry’s COVID-19 self-assessment.

Public Health Reporting Requirements

As outlined in the Ministry of Health’s COVID-19 Provincial Testing Guidance, positive rapid antigen test results do not require confirmatory testing in most settings, or reporting to the public health unit, unless otherwise recommended by the public health unit or sector specific guidance.

Other than rapid antigen tests and self-test kits, positive COVID-19 tests performed using a Health Canada approved test or an assay validated by the laboratory must be reported to the local public health unit under the Health Protection and Promotion Act. You can find the contact information for your local public health unit using the Ministry’s Public Health Unit Locator.

Hospital pharmacists and technicians should be familiar with the hospital’s policy and procedures, including the expectation of pharmacists, if any, for reporting suspected cases of COVID-19 among inpatients and outpatients.

Resources from Associations

A number of pharmacy associations have made their COVID-19 resources available to all pharmacy professionals, including:

PATIENT CARE

Paxlovid™ – Prescribing & Dispensing

May 2023 update: Ontario Health is advising that Paxlovid™ can cause severe interactions with some transplant medications and solid organ transplant recipients should not take Paxlovid™ without first speaking to their transplant care team. Solid organ transplant recipients who test positive for COVID-19 should be directed to contact their transplant care team to receive the appropriate COVID-19 therapeutics and follow-up care.

As announced by the Ontario government, as of December 12, 2022, O. Reg.107/96 – Controlled Acts, under the Regulated Health Professions Act (RHPA), was amended to authorize a Part A pharmacist to prescribe Paxlovid™ (nirmatrelvir/ritonavir) antiviral treatment for COVID-19 in accordance with section 16 of the regulation and the eligibility criteria set out by the Ministry of Health.

Pharmacists must possess the required clinical knowledge, skills and competency to prescribe and/or dispense Paxlovid™ for eligible individuals. A comprehensive patient assessment is required to identify and manage potential drug therapy problems (such as drug interactions, contraindications, the need for dosage adjustments, etc.) or to determine whether a referral to a primary care provider is necessary. Pharmacists offering this service must follow expectations outlined in the Initiating, Adapting and Renewing Prescriptions Guideline.

Additional resources to support pharmacists with clinical decision-making and links to the Ministry of Health Executive Officer notices can be found below. Resources related to screening protocols and IPAC measures can be found under Pharmacy Operations – Infection Prevention and Control Measures.

No other registrant (i.e., Part B pharmacist, registered pharmacy student, intern, pharmacy technician, pharmacist (emergency assignment), or pharmacy technician (emergency assignment)) is authorized to prescribe Paxlovid™.

For more information, please reference the resources below:

Ontario COVID-19 Science Advisory Table
- COVID-19 Drug Interactions Checker
University of Waterloo School of Pharmacy / University of Toronto Leslie Dan Faculty of Pharmacy
- Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know
- Paxlovid for a Patient on a DOAC
Canadian Pharmacists Association
- Treatment of COVID-19 with Paxlovid™

Centre for Effective Practice (CEP)
- COVID-19: Clinical Guidance for Primary Care Providers
Government of Canada
- COVID-19 vaccines and treatments portal

Renal function (eGFR) calculators (examples):

Controlled Drugs and Substances Act (CDSA) Exemption

Health Canada’s section 56 (1) exemption from the Controlled Drugs and Substances Act has been extended to September 30, 2026 authorizing pharmacists to:

Accept a verbal order from a prescriber for a controlled substance.
Transfer a prescription for a narcotic or controlled drug to another pharmacist in Canada. If it has already been transferred, it may be transferred to another pharmacist.
Transfer a prescription for a benzodiazepine or other targeted substance to another pharmacist. If it has already been transferred, it may be transferred to another pharmacist.
Refill a prescription for a benzodiazepine or other targeted substance if more than one year has elapsed since the date it was written
Renew a prescription for a controlled substance.
Adapt a prescription for a controlled substance, including part-filling or de-prescribing.

To align with this extension, amendments to O. Reg. 202/94 (General) made under the Pharmacy Act, 1991 have been approved by the Ontario government. These changes continue to temporarily allow pharmacists to renew and adapt prescriptions for controlled drugs and substances until September 30, 2026.

Health Canada has also issued:

Please contact Health Canada for questions concerning the exemption at HC.compliance-conformite.SC@canada.ca.

CDSA Exemption – OCP Resources for Pharmacy Professionals

To support the profession in adapting to these temporary CDSA changes, the College has updated a number of resources for pharmacy professionals to reflect these interim measures:

COVID-19 Testing and Screening in Community Pharmacies

See the Ministry of Health COVID-19 Guidance for the Health Sector – Symptoms, Screening and Testing Resources

COVID-19 Testing (Laboratory Based PCR Testing)

The College has created GUIDANCE – Providing COVID-19 Services in Community Pharmacies outlining the College’s expectations for Designated Managers, registrants and community pharmacies opting to provide COVID-19 testing (including the specimen collection required to perform a test) to the public.

For information on publicly-funded laboratory-based PCR testing in pharmacies, refer to the Ministry of Health Executive Officer Notices.

COVID-19 Screening (Antigen Point-of-Care Testing (POCT))

Exemptions enacted under the Laboratory and Specimen Collection Centre Licensing Act allow any person to collect specimens for COVID-19 point-of-care testing. When performed by pharmacy professionals, the Standards of Practice and Code of Ethics expect registrants to recognize and work within the limits of their competence and to only practice when they have the appropriate knowledge and skill to do so safely. Training materials for conducting antigen POCTs are available from Ontario Health.

For these and any other COVID-19 testing and screening initiatives, please refer to Ministry of Health COVID-19 Guidance for the Health Sector – Symptoms, Screening and Testing Resources. For further inquiries, please send an email to: PublicDrugPrgrms.moh@ontario.ca.

Managing Opioid Agonist Treatment (OAT)

CRISM Guidance

The Canadian Research Initiative in Substance Misuse (CRISM) has developed six national guidance documents to address the urgent needs of people who use substances, service providers and decision makers in relation to the COVID-19 pandemic.

Access the six guidance documents.

CAMH Guidance

The Centre for Addiction and Mental Health (CAMH) has provided new guidance to pharmacists and prescribers for dispensing and prescribing of OAT that will assist in the provision of collaborative patient care during COVID-19 pandemic.

PHARMACY OPERATIONS

Infection Prevention and Control Resources

Please see the following resources related to implementing and maintaining infection prevention and control activities:

IPAC Measures Memo from Ontario’s Chief Medical Officer of Health (December 30, 2021)
Best Practices for Environmental Cleaning for Prevention and Control of Infections in All Care Settings (Public Health Ontario)
IPAC Recommendations for Use of Personal Protective Equipment for Care of Individuals with Suspect or Confirmed COVID-19
(Public Health Ontario)
Patient Safety and Infection Prevention and Control (Winter 2020 Pharmacy Connection article)
A Pharmacist’s Guide to Pandemic Preparedness, see Environmental Cleaning section (Ontario Pharmacists Association)
PPE: Suggested Best Practices for Pharmacies During the COVID-19 Pandemic (Canadian Pharmacists Association)
Interim COVID-19 infection prevention and control in the health care setting when COVID-19 is suspected or confirmed (Government of Canada)
Optimizing the Supply of PPE During the COVID-19 Pandemic (Ontario Health)

About The College

Board (Council) & Committees

Performance & Accountability

Equity, Diversity & Inclusion

Protecting the Public

You & Your Pharmacy

About Find a Pharmacy or Pharmacy Professional

Complaints & Reports

Pharmacy Operational Assessment Process

Discipline Process

Professional Registration

Register as a Pharmacist

Register as a Pharmacy Technician

Registration Requirements

Fees & Timelines

Resolutions & Policies

Maintaining Your Registration

Two Part Register for Pharmacists

Practice & Education

Practice Tools

Quality Assurance Program

Opening & Operating a Pharmacy

Opening & Operating a Hospital Pharmacy

Quality Improvement Data for Pharmacy

Expanded Scope of Practice

Regulations & Standards

AIMS (Assurance and Improvement in Medication Safety)

Practice Policies & Guidelines

News & Resources

Key Initiatives & Consultations

Key Initiatives

COVID-19: Information for Pharmacy Professionals

Jump To:

Helpful Links